|
|
|
Biosimilar Drug Product Development
|
(Buch) |
Dieser Artikel gilt, aufgrund seiner Grösse, beim Versand als 3 Artikel!
| Lieferstatus: |
 Auf Bestellung (Lieferzeit unbekannt) |
| Veröffentlichung: |
März 2017
|
| Genre: |
Naturwissensch., Medizin, Technik |
|
|
ADA Formation / ADA Response / advanced biosimilar regulatory pathways / Animal Studies / Biological Medicinal Product / Biology, life sciences / Biosimilar Candidate / Biosimilar Infliximab |
| ISBN: |
9781498718790 |
|
EAN-Code:
|
9781498718790 |
| Verlag: |
Taylor and Francis |
| Einband: |
Gebunden |
| Sprache: |
English
|
| Serie: |
Drugs and the Pharmaceutical Sciences |
| Dimensionen: |
H 234 mm / B 156 mm / D |
| Gewicht: |
904 gr |
| Seiten: |
496 |
| Illustration: |
schwarz-weiss Illustrationen, farbige Illustrationen, Raster,schwarz-weiss, Raster, farbig, Zeichnungen, schwarz-weiss, Zeichnungen, farbig, Tabellen, schwarz-weiss |
| Bewertung: |
Titel bewerten / Meinung schreiben
|
| Inhalt: |
| When a biological drug patent expires, alternative biosimilar products are developed. The development of biosimilar products is complicated and involves numerous considerations and steps. The assessment of biosimilarity and interchangeability is also complicated and difficult. Biosimilar Drug Product Development presents current issues for the development of biosimilars and gives detailed reviews of its various stages and contributing factors as well as relevant regulatory pathways and pre- and post-approval issues. |
|
Newsfeed | 
Facebook | 
Twitter
